ESTIMATED
11/14/2022
11/14/2022
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Ampio Pharmaceuticals, Inc. last posted its earnings results on Monday, November 14th, 2022. The company reported $-10 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02 by $9.98. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Ampio Pharmaceuticals, Inc. has generated $-11 earnings per share over the last year ($-10.66 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. Ampio Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 03/27/2024 | Q4 2023 | -$2.48 | $0 | $0 | 11/14/2023 | Q3 2023 | -$1.53 | $0 | $0 | 08/08/2023 | Q2 2023 | -$1.82 | $0 | 05/08/2023 | Q1 2023 | -$4.87 | $0 | 03/27/2023 | Q4 2022 | -$2.79 | $0 | 11/14/2022 | Q3 2022 | -$0.02 | -$8.61 | -8.59 | $0 | 08/09/2022 | Q2 2022 | -$6.00 | -$2.79 | 3.21 | $0 | 05/16/2022 | Q1 2022 | -$6.00 | -$7.48 | -1.48 | $0 | 03/29/2022 | Q4 2021 | -$0.47 | $0 | 11/10/2021 | Q3 2021 | -$6.00 | -$5.40 | 0.6 | $0 | 08/04/2021 | Q2 2021 | -$6.00 | -$6.00 | 0 | $0 | 05/05/2021 | Q1 2021 | -$6.00 | -$6.00 | 0 | $0 | 03/03/2021 | Q4 2020 | -$6.00 | -$0.30 | 5.7 | $0 | 11/03/2020 | Q3 2020 | -$6.00 | -$6.00 | 0 | $0 | 07/31/2020 | Q2 2020 | -$11.99 | -$6.00 | 5.99 | $0 | 05/06/2020 | Q1 2020 | -$11.99 | -$9.00 | 2.99 | $0 | 02/21/2020 | Q4 2019 | -$0.01 | $0.00 | $365,828 | 11/07/2019 | Q3 2019 | -$0.60 | -$15.00 | -14.4 | $0 | 08/09/2019 | Q2 2019 | $1.10 | $0 | 05/10/2019 | Q1 2019 | -$15.00 | $79,000 |
---|
A. Ampio Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates.
A. The conference call for Ampio Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Ampio Pharmaceuticals, Inc.'s latest earnings report can be read online.
A. Ampio Pharmaceuticals, Inc. (AMEX:AMPE) has a recorded net income of $0. Ampio Pharmaceuticals, Inc. has generated $-10.66 earnings per share over the last four quarters.
A. Ampio Pharmaceuticals, Inc. (AMEX:AMPE) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is -0.